{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:18:42Z","timestamp":1771978722922,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s10067-017-3574-0","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T07:42:53Z","timestamp":1487230973000},"page":"971-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Recovery of nail dystrophy potential new therapeutic indication of tofacitinib"],"prefix":"10.1007","volume":"36","author":[{"given":"Jose A.","family":"Jaller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Jaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio M.","family":"Jaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"Jaller-Char","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sineida Berbert","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morton","family":"Scheinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"3574_CR1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1358\/dot.2016.52.8.2543995","volume":"52","author":"S Lam","year":"2016","unstructured":"Lam S (2016) JAK inhibitors:a broadening approach in rheumatoid arthritis. Drugs Today 52:467\u2013469","journal-title":"Drugs Today"},{"issue":"1","key":"3574_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10067-016-3436-1","volume":"36","author":"R1 Fleischmann","year":"2017","unstructured":"Fleischmann R1, Mease PJ2, Schwartzman S3, Hwang LJ4, Soma K5, Connell CA5, Takiya L6, Bananis E7 (2017) Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group. Clin Rheumatol 36(1):15\u201324","journal-title":"Clin Rheumatol"},{"key":"3574_CR3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski","year":"2016","unstructured":"Roskoski R (2016) Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res 111:784\u2013803","journal-title":"Pharmacol Res"},{"key":"3574_CR4","doi-asserted-by":"crossref","unstructured":"Kostovic K, Gulin SJ, Mokos ZB, Ceovic R (2017) Tofacitinib an oral Janus kinase inhibitor: perspectives in dermatology Curr Med Chem Jan 2012","DOI":"10.2174\/1874467210666170113104503"},{"key":"3574_CR5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1468-3083.2008.02830.x","volume":"23","author":"E Kasumagic-Halilovic","year":"2009","unstructured":"Kasumagic-Halilovic E, Prohic A (2009) Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol 23:240\u2013241","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3574_CR6","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1038\/jid.2014.260","volume":"134","author":"BG Craiglow","year":"2014","unstructured":"Craiglow BG, King BA (2014) Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis. J Invest Dermatol 134:2988\u20132990","journal-title":"J Invest Dermatol"},{"key":"3574_CR7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7326\/L16-0125","volume":"165","author":"M Scheinberg","year":"2016","unstructured":"Scheinberg M, Ferreira SB (2016) Reversal of alopecia universalis by tofacitinib: a case report. Ann Intern Med 165:750\u2013751","journal-title":"Ann Intern Med"},{"issue":"3","key":"3574_CR8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000450848","volume":"8","author":"SB Ferreira","year":"2016","unstructured":"Ferreira SB, Scheinberg M, Steiner D, Steiner T, Bedin GL, Ferreira RB (2016) Remarkable improvement of nail changes in alopecia areata universalis with 10\u00a0months of treatment with tofacitinib: a case report. Case Rep Dermatol 8(3):262\u2013266","journal-title":"Case Rep Dermatol"},{"key":"3574_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0190-9622(91)70194-7","volume":"25","author":"A Tosti","year":"1991","unstructured":"Tosti A, Fanti PA, Morelli R, Bardazzi F (1991) Trachyonychia associated with alopecia areata: a clinical and pathological study. J Am Acad Dermatol 25:266\u2013270","journal-title":"J Am Acad Dermatol"},{"key":"3574_CR10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamadermatol.2015.3772","volume":"152","author":"A Dhayalan","year":"2016","unstructured":"Dhayalan A, King BA (2016) Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis. JAMA Dermatol 152:492\u2013493","journal-title":"JAMA Dermatol"},{"key":"3574_CR11","doi-asserted-by":"crossref","unstructured":"Gao Q, Liang X, Shaikh AS, Zang J, Xu W, Zhang Y (2016) JAK\/STAT signal transduction: promising attractive targets for immune, inflammatory and hematopoietic diseases. Curr Drug Targets 7","DOI":"10.2174\/1389450117666161207163054"},{"key":"3574_CR12","unstructured":"Liu LY, Craiglow BG, Dai F, King BA (2016) Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients. J Am Acad Dermatol pii: S0190\u20139622(16)30763\u20130"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3574-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3574-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:04:40Z","timestamp":1568833480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3574-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3574"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3574-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]}}}